Blue Xanax 1mg
What is Xanax and how is it used?
Xanax is a prescription medicine used to treat the symptoms of anxiety, panic disorder, and anxiety associated with depression. Buy Blue Xanax 1mg may be used alone or with other medications.
Blue Xanax belongs to a class of drugs called Antianxiety Agents, Anxiolytics, and Benzodiazepines.
DOSAGE AND ADMINISTRATION
Dosage In Generalized Anxiety Disorder
For the acute treatment of GAD, XANAX is recommended to be taken three times daily at a starting dose of 0.25 mg to 0.5 mg. It is possible to adjust the dosage every 3 to 4 days based on the response. There is a maximum recommended dose of 4 mg per day (divided into two doses).
Dosage In Panic Disorder
The recommended starting oral dosage of Xanax 1mg for the treatment of PD is 0.5 mg three times daily. Depending on the response, the dosage may be increased at intervals of every 3 to 4 days in increments of no more than 1 mg per day.
Controlled trials of Buy Xanax XR 3mg in the treatment of panic disorder included dosages in the range of 1 mg to 10 mg daily. Occasional patients required as much as 10 mg per day.
For patients receiving doses greater than 4 mg per day, periodic reassessment and consideration of dosage reduction is advised.
Risks From Concomitant Use With Opioids
Concomitant use of benzodiazepines, including Xanax 1mg, and opioids may result in profound sedation, respiratory depression, coma, and death. Because of these risks, concomitant reserve prescribing of these drugs in patients with inadequate alternative treatment options.
Observational studies have demonstrated that concomitant use of opioid analgesics and benzodiazepines increases the risk of drug-related mortality compared to the use of opioids alone.
Advise both patients and caregivers about the risks of respiratory depression and sedation when XANAX is used with opioids. Advise patients not to drive or operate heavy machinery until the effects of concomitant use with the opioid have been determined [see DRUG INTERACTIONS].
There are no reviews yet.